| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Silymarin | Chikungunya Virus Infection | 2 | PM | 32121393 | 📋 | Antivirals Against Chikungunya Virus: Is the Solution in Nature? |
| Silymarin | Chikungunya Virus Infection | 1 | PM | 26078201 | 📋 | Antiviral Activity of Silymarin Against Chikungunya Virus |
| Silymarin | COVID-19 Infection | 1 | PM | 33807773 | 📋 | SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome |
| Silymarin | Dengue Fever | 1 | PM | 34707245 | 📋 | Antiviral activity of silymarin and baicalein against dengue virus |
| Silymarin | Enterovirus Infection | 1 | PM | 32293397 | 📋 | Antiviral Activity of Silymarin in Comparison With Baicalein Against EV-A71 |
| Silymarin | Hand Foot and Mouth Disease | 1 | PM | 32293397 | 📋 | Antiviral Activity of Silymarin in Comparison With Baicalein Against EV-A71 |
| Silymarin | Hepatitis C | 4 | PM | 35154575 | 📋 | Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial |
| Silymarin | Hepatitis C | 9 | PM | 33583390 | 📋 | Effect of Direct-Acting Antiviral Drugs on Erectile Functions among Hepatitis C Patients: A Prospective Interventional Study |
| Silymarin | Hepatitis C | 3 | PM | 29135373 | 📋 | High Dose of Silymarin in Patients With Decompensated Liver Disease: A Randomized Controlled Trial |
| Silymarin | Hepatitis C | 5 | PM | 22497849 | 📋 | Spirulina Platensis Versus Silymarin in the Treatment of Chronic Hepatitis C Virus Infection. A Pilot Randomized, Comparative Clinical Trial |
| Silymarin | Hepatitis C | 7 | PM | 19782083 | 📋 | Silymarin Inhibits in Vitro T-cell Proliferation and Cytokine Production in Hepatitis C Virus Infection |
| Silymarin | Hepatitis C | 8 | PM | 17484885 | 📋 | Inhibition of T-cell Inflammatory Cytokines, Hepatocyte NF-kappaB Signaling, and HCV Infection by Standardized Silymarin |
| Silymarin | Hepatitis C | 2 | PM | 16082287 | 📋 | Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial |
| Silymarin | Hepatitis C | 1 | PM | 10554539 | 📋 | A Conservative Triple Antioxidant Approach to the Treatment of Hepatitis C. Combination of Alpha Lipoic Acid (Thioctic Acid), Silymarin, and Selenium: Three Case Histories |
| Silymarin | Infectious Disease | 1 | PM | 27273551 | 📋 | Artichoke and Milk Thistle Pills and Syrups as Sources of Phenolic Compounds With Antimicrobial Activity |
| Silymarin | Viral Infection | 3 | PM | 37249707 | 📋 | Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review |
| Silymarin | Viral Infection | 1 | PM | 30076863 | 📋 | Antiviral Activity of Silymarin Against Mayaro Virus and Protective Effect in Virus-Induced Oxidative Stress |
| Silymarin | Zika Virus Infection | 1 | PM | 32621935 | 📋 | Antiviral Effect of Silymarin Against Zika Virus in Vitro |
